Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. British American Tobacco Plc
  6. News
  7. Summary
    BATS   GB0002875804

BRITISH AMERICAN TOBACCO PLC

(BATS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

British American Tobacco : Our Science & Innovation Report – available now

06/09/2021 | 04:03am EDT

Science and innovation are at the heart of our transformational journey as we continue to build A Better TomorrowTM by reducing the health impact of our business.

Available to download at bat-science.com , the new Science & Innovation Report showcases our latest scientific research into New Category products and puts the spotlight on our world-class scientists and teams who are accelerating our transformation. It also looks to the future as we move into bold new areas and expand our portfolio Beyond Nicotine.

Published every two years, the report highlights how our 1,500 R&D specialists are accelerating our harm reduction mission and how our teams around the world have remained resilient during the COVID-19 pandemic. We explore our work in the cannabidiol (CBD) space and deep dive into our vaccine development in the US. We also highlight the importance of openly communicating our science with a broad range of stakeholders, having proudly have welcomed more than 3,500 visitors to our science exhibition, R&D Live, since it opened at our R&D hub in Southampton, UK, in 2011.

Dr David O'Reilly, Director, Scientific Research, says: 'Science is the driving force of today's society, and scientists are forever pushing at the boundaries to discover solutions that can transform or enhance our lives. The pandemic has showed us that science has never been more important to the way we live, work, and function.

'As a business, we are also at the scientific forefront, demonstrating a relentless commitment to our core purpose - to build A Better Tomorrow for our consumers, society, employees, and shareholders. Despite the challenges we have all faced in these past months, our team has continued to focus on how science can move us towards that purpose.

'I hope this thought-provoking report inspires you as much as it does me, and that you will join us on this journey of innovation.'

Download the report at bat-science.com and follow us on Twitter @BATplc and @BAT_Sci for updates.

Disclaimer

British American Tobacco plc published this content on 09 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 June 2021 08:02:06 UTC.


ę Publicnow 2021
All news about BRITISH AMERICAN TOBACCO PLC
08/04BRITISH AMERICAN TOBACCO : Notification and public disclosure of transactions by..
PU
08/02IN CONFORMITY WITH THE DISCLOSURE GU : (Form 6-K)
PU
07/29BRITISH AMERICAN TOBACCO : JPMorgan Boosts British American Tobacco PT, Affirms ..
MT
07/29BAT : JP Morgan reiterates its Neutral rating
MD
07/29BAT : Deutsche Bank reaffirms its Buy rating
MD
07/28European ADRs Move Higher in Wednesday Trading
MT
07/28BAT : RBC remains its Buy rating
MD
07/28BAT : Jefferies maintains a Buy rating
MD
07/28BAT : JP Morgan sticks Neutral
MD
07/28BRITISH AMERICAN TOBACCO : Alternative Products Sales Surge Help Keep First-Half..
MT
More news
Financials
Sales 2021 25 588 M 35 641 M 35 641 M
Net income 2021 7 008 M 9 762 M 9 762 M
Net Debt 2021 38 037 M 52 982 M 52 982 M
P/E ratio 2021 8,57x
Yield 2021 8,18%
Capitalization 60 796 M 84 704 M 84 683 M
EV / Sales 2021 3,86x
EV / Sales 2022 3,62x
Nbr of Employees 56 689
Free-Float 87,1%
Chart BRITISH AMERICAN TOBACCO PLC
Duration : Period :
British American Tobacco Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRITISH AMERICAN TOBACCO PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 2 656,50 GBX
Average target price 3 562,10 GBX
Spread / Average Target 34,1%
EPS Revisions
Managers and Directors
Jack Marie Henry David Bowles Chief Executive Officer & Executive Director
Tadeu Luiz Marroco Executive Director & Finance Director
Luc Jobin Chairman
David O'Reilly Director-Scientific Research
Marina Fagundes Bellini Director-Digital & Information